Nathan Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 21-12-2024
- Paid Up Capital ₹ 7.50 M
as on 21-12-2024
- Company Age 4 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 Cr
as on 21-12-2024
- Revenue %
(FY 2024)
- Profit -31.12%
(FY 2024)
- Ebitda -149.56%
(FY 2024)
- Net Worth -6.27%
(FY 2024)
- Total Assets 210.71%
(FY 2024)
About Nathan Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹6.50 Cr.
Amit Jain and Sumit Jain serve as directors at the Company.
- CIN/LLPIN
U24290HP2020PTC008227
- Company No.
008227
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nathan Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Jain  | Director | 24-Nov-2020 | Current |
| Amit Jain | Director | 24-Nov-2020 | Current |
Financial Performance of Nathan Pharma.
Nathan Pharma Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 31.12% decrease in profit. The company's net worth dipped by a decrease of 6.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nathan Pharma?
Unlock access to Nathan Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Devarya Life Sciences Private LimitedActive 4 years 7 monthsAmit Jain and Sumit Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2023 | ₹6.50 Cr | Open |
How Many Employees Work at Nathan Pharma?
Unlock and access historical data on people associated with Nathan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nathan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nathan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
